arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

biote Corp.

BTMD

$1.48 ▼ -0.11 (-6.92%) at close

6 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bearish

auto_awesome

Analytical Summary

biote Corp. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $46.3M

Dividend Yield —

Revenue Growth -2.5% ↘

Op. Margin 18.5% ↗

ROIC 67.0% ↗

FCF / Share $0.96 ↘

Trailing P/E 1.7x

Price / Book —

FCF Yield 65.2%

Debt / Equity -1.76

info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$192.22M

↓ -2.5% —

Net Income Profit after all expenses

$27.05M

↑ +756.7% —

Operating Margin Operating profit as % of sales

18.5%

↑ +15.4% 73th

FCF / Share Free cash flow per share

$0.96

↓ -14.8% —

Long-Term Debt Long-term obligations

$103.12M

↓ -5.7% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-2.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-150%)	6.4% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+28%)	12.4% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+147%)	18.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+267%)	—	—
EPS Growth YoY (%)	855.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-30.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—
Net Income Growth YoY (%)	756.7% Excellent Excellent Year-over-year change in net income	-4.8% Weak Weak Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%)	-14.8% Weak Weak Year-over-year change in free cash flow	9.8% Fair Fair Year-over-year change in free cash flow	N/M	—	—	—
Revenue CAGR 3Y (%)	5.2% Fair Fair Compound annual revenue growth over 3 years	12.3% Good Good Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	18.5% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+23%)	16.0% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+7%)	15.5% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-36.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-345%)	24.8% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+65%)	—
Effective Tax Rate (%) (%)	15.9% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	95.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2180.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	22.7% Fair Fair Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	14.1% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+41%)	1.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-84%)	1.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-82%)	-0.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-106%)	23.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+134%)	—
FCF Margin (%) (%)	15.7% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	19.7% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	14.3% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	23.2% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.12x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	12.29x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	8.00x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	9.79x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	67.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	41.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	757.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-60.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	94.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	33.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	25.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	18.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-54.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	63.6% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-46.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-485%)	-3.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-11.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	2.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-82%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	-1.76x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-452%)	-1.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-307%)	-3.93x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-887%)	-2.74x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-648%)	7.75x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1450%)	—
Interest Coverage (x)	4.51x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	3.32x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	3.02x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	-13.72x Weak Weak Operating income divided by interest expense Optimal: > 5x	23.64x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$79.00M	$70.03M	$26.62M	$121.88M	$31.96M	$-1.59K
Debt / EBITDA (x)	2.63x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.11x Caution ↑ Caution Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.65x Caution ↑ Caution Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.89x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$6.14	$5.75	$7.21	$20.47	—	—
Basic EPS, GAAP (USD)	$0.86	$0.09	$0.13	$-0.12	—	—
Free Cash Flow per Share (USD)	$0.96	$1.13	$1.03	$-1.18	—	—
Book Value per Share (USD)	$-1.87	$-3.09	$-1.14	$-0.76	—	—
Tangible Book Value per Share (USD)	$-2.19	$-3.42	$-1.14	$-0.76	—	—
Basic Weighted Avg Shares (shares)	31.28M	34.27M	25.71M	8.06M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$9.68M	$16.61M	$100.13M	$82.41M	$29.77M	$-120.91K
LT Debt (USD)	$103.12M	$109.38M	$115.62M	$121.88M	$31.96M	—
Total Equity (USD)	$-58.54M	$-105.93M	$-29.40M	$-44.46M	$4.12M	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$192.22M	$197.19M	$185.36M	$164.96M	$139.40M	—
Depreciation Expense (USD)	$3.67M	$3.57M	$2.99M	$2.20M	$1.40M	—
Net Income, GAAP (USD)	$27.05M	$3.16M	$3.32M	$-969.00K	$32.62M	—
Operating Cash Flow (USD)	$35.19M	$45.24M	$26.88M	$-9.16M	$33.72M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

biote Corp.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BTMD with peers